Dr. Mitchell Levy, MD
Claim this profileRhode Island Hospital
Studies Pre-eclampsia
Studies Septicemia
2 reported clinical trials
58 drugs studied
Affiliated Hospitals
Clinical Trials Mitchell Levy, MD is currently running
Sepsis Bundle
for Sepsis
Since the introduction of sepsis bundles, there have been multiple published trials that have demonstrated a consistent, strong association between implementation of sepsis "bundles" (3-hour bundle) and improved survival. The current proposal is a Hybrid 2, pragmatic, cluster randomized clinical effectiveness/implementation trial evaluating mortality and respiratory failure-based outcomes, in patients admitted to the emergency department with sepsis, comparing the effectiveness of implementation of the hour-1 bundle to 3-hour bundle, while facilitating adherence to both bundles. In addition, 4 distinct sepsis phenotypes will be derived from routine clinical data to identify specific patient phenotypes that allow for a more precision-based application of sepsis bundles in future studies.
Recruiting1 award N/A
Multiple Treatments
for Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.
Recruiting3 awards Phase 33 criteria
More about Mitchell Levy, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mitchell Levy, MD has experience with
- Sepsis Bundle
- Amoxicillin-clavulanate
- Anakinra
- Angiotensin Converting Enzyme Inhibitor
- Angiotensin Receptor Blockers
- Apremilast
Breakdown of trials Mitchell Levy, MD has run
Pre-eclampsia
Septicemia
Sepsis
Coronavirus
Neonatal Pneumonia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mitchell Levy, MD specialize in?
Mitchell Levy, MD focuses on Pre-eclampsia and Septicemia. In particular, much of their work with Pre-eclampsia has involved treating patients, or patients who are undergoing treatment.
Is Mitchell Levy, MD currently recruiting for clinical trials?
Yes, Mitchell Levy, MD is currently recruiting for 2 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Mitchell Levy, MD has studied deeply?
Yes, Mitchell Levy, MD has studied treatments such as Sepsis Bundle, Amoxicillin-clavulanate, Anakinra.
What is the best way to schedule an appointment with Mitchell Levy, MD?
Apply for one of the trials that Mitchell Levy, MD is conducting.
What is the office address of Mitchell Levy, MD?
The office of Mitchell Levy, MD is located at: Rhode Island Hospital, Providence, Rhode Island 02903 United States. This is the address for their practice at the Rhode Island Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.